{"id":11320,"date":"2024-02-28T07:00:00","date_gmt":"2024-02-28T06:00:00","guid":{"rendered":"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-vid-konferensen-bayeslund-2024-i-lund-den-7-mars\/"},"modified":"2024-02-28T07:00:00","modified_gmt":"2024-02-28T06:00:00","slug":"irlab-presenterar-vid-konferensen-bayeslund-2024-i-lund-den-7-mars","status":"publish","type":"mfn_news","link":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-vid-konferensen-bayeslund-2024-i-lund-den-7-mars\/","title":{"rendered":"IRLAB presenterar vid konferensen Bayes@Lund 2024 i Lund den 7 mars"},"content":{"rendered":"
\n

G\u00f6teborg den 28 februari 2024 \u2013 IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), ett f\u00f6retag som uppt\u00e4cker och utvecklar nya behandlingar f\u00f6r Parkinsons sjukdom, meddelade idag att f\u00f6retaget kommer att h\u00e5lla en presentation p\u00e5 den vetenskapliga konferensen Bayes@Lund 2024 den 7 mars 2024.<\/strong><\/p>\n<\/div>\n

\n

IRLAB:s abstract beskriver anv\u00e4ndningen av Bayesianska modeller vid planering och utf\u00f6rande av kliniska studier och har titeln \u201dUsing a Bayesian model for clinical study design and blinded data review.\u201d Presentationen har blivit accepterad som en muntlig presentation som kommer att h\u00e5llas av IRLAB:s medarbetare Erik Werner den 7 mars och kommer att g\u00f6ras tillg\u00e4nglig p\u00e5 YouTube efter att konferensen avslutats.<\/p>\n

F\u00f6r mer information om konferensen, bes\u00f6k g\u00e4rna\u00a0https:\/\/www.bayesatlund.com<\/a><\/p>\n<\/div>\n

\n

F\u00f6r mer information:<\/strong><\/p>\n

\n

Gunnar Olsson, VD
Telefon: +46 70 576 14 02
E-mail:\u00a0gunnar.olsson@irlab.se<\/a><\/p>\n<\/div>\n

\n

Om IRLAB<\/strong><\/p>\n

\n

IRLAB uppt\u00e4cker och utvecklar en portf\u00f6lj av transformativa behandlingar f\u00f6r alla stadier av Parkinsons sjukdom. Bolaget har sitt ursprung i Nobelpristagaren Prof. Arvid Carlssons forskargrupp och uppt\u00e4ckten av ett samband mellan hj\u00e4rnans signalsubstanser och CNS-st\u00f6rningar. Mesdopetam (IRL790), under utveckling f\u00f6r behandling av levodopa-inducerade dyskinesier, har slutf\u00f6rt Fas IIb och \u00e4r i f\u00f6rberedelse f\u00f6r Fas III. Pirepemat (IRL752), befinner sig f\u00f6r n\u00e4rvarande i Fas IIb, och utv\u00e4rderas f\u00f6r sin effekt p\u00e5 balans och fallfrekvens vid Parkinson. Dessutom utvecklar bolaget \u00e4ven de tre prekliniska programmen IRL757 (med finansiering fr\u00e5n Michael J. Fox Foundation), IRL942 och IRL1117 mot Fas I-studier. IRLAB:s pipeline har genererats av bolagets egenutvecklade systembiologibaserade forskningsplattform Integrative Screening Process (ISP). IRLAB har sitt huvudkontor i Sverige och \u00e4r noterat p\u00e5 Nasdaq Stockholm (IRLAB A). F\u00f6r mer information, bes\u00f6k\u00a0www.irlab.se<\/a>.<\/p>\n<\/div>\n

\n

Bifogade filer<\/strong><\/p>\n

\n

IRLAB presenterar vid konferensen Bayes@Lund 2024 i Lund den 7 mars<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

G\u00f6teborg den 28 februari 2024 \u2013 IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), ett f\u00f6retag som uppt\u00e4cker och utvecklar nya behandlingar f\u00f6r Parkinsons sjukdom, meddelade idag att f\u00f6retaget kommer att h\u00e5lla en presentation p\u00e5 den vetenskapliga konferensen Bayes@Lund 2024 den 7 mars 2024.<\/p>\n","protected":false},"template":"","class_list":["post-11320","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-other_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"\nIRLAB presenterar vid konferensen Bayes@Lund 2024 i Lund den 7 mars - IRLAB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-vid-konferensen-bayeslund-2024-i-lund-den-7-mars\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IRLAB presenterar vid konferensen Bayes@Lund 2024 i Lund den 7 mars - IRLAB\" \/>\n<meta property=\"og:description\" content=\"G\u00f6teborg den 28 februari 2024 \u2013 IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), ett f\u00f6retag som uppt\u00e4cker och utvecklar nya behandlingar f\u00f6r Parkinsons sjukdom, meddelade idag att f\u00f6retaget kommer att h\u00e5lla en presentation p\u00e5 den vetenskapliga konferensen Bayes@Lund 2024 den 7 mars 2024.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-vid-konferensen-bayeslund-2024-i-lund-den-7-mars\/\" \/>\n<meta property=\"og:site_name\" content=\"IRLAB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-vid-konferensen-bayeslund-2024-i-lund-den-7-mars\/\",\"url\":\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-vid-konferensen-bayeslund-2024-i-lund-den-7-mars\/\",\"name\":\"IRLAB presenterar vid konferensen Bayes@Lund 2024 i Lund den 7 mars - IRLAB\",\"isPartOf\":{\"@id\":\"https:\/\/irlab.se\/#website\"},\"datePublished\":\"2024-02-28T06:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-vid-konferensen-bayeslund-2024-i-lund-den-7-mars\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-vid-konferensen-bayeslund-2024-i-lund-den-7-mars\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-vid-konferensen-bayeslund-2024-i-lund-den-7-mars\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/irlab.se\/sv\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\/\/irlab.se\/sv\/pressmeddelanden\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"IRLAB presenterar vid konferensen Bayes@Lund 2024 i Lund den 7 mars\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/irlab.se\/#website\",\"url\":\"https:\/\/irlab.se\/\",\"name\":\"Irlab\",\"description\":\"Novel treatments for Parkinson's disease\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/irlab.se\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IRLAB presenterar vid konferensen Bayes@Lund 2024 i Lund den 7 mars - IRLAB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-vid-konferensen-bayeslund-2024-i-lund-den-7-mars\/","og_locale":"sv_SE","og_type":"article","og_title":"IRLAB presenterar vid konferensen Bayes@Lund 2024 i Lund den 7 mars - IRLAB","og_description":"G\u00f6teborg den 28 februari 2024 \u2013 IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), ett f\u00f6retag som uppt\u00e4cker och utvecklar nya behandlingar f\u00f6r Parkinsons sjukdom, meddelade idag att f\u00f6retaget kommer att h\u00e5lla en presentation p\u00e5 den vetenskapliga konferensen Bayes@Lund 2024 den 7 mars 2024.","og_url":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-vid-konferensen-bayeslund-2024-i-lund-den-7-mars\/","og_site_name":"IRLAB","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-vid-konferensen-bayeslund-2024-i-lund-den-7-mars\/","url":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-vid-konferensen-bayeslund-2024-i-lund-den-7-mars\/","name":"IRLAB presenterar vid konferensen Bayes@Lund 2024 i Lund den 7 mars - IRLAB","isPartOf":{"@id":"https:\/\/irlab.se\/#website"},"datePublished":"2024-02-28T06:00:00+00:00","breadcrumb":{"@id":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-vid-konferensen-bayeslund-2024-i-lund-den-7-mars\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-vid-konferensen-bayeslund-2024-i-lund-den-7-mars\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-vid-konferensen-bayeslund-2024-i-lund-den-7-mars\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/irlab.se\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/irlab.se\/sv\/pressmeddelanden\/"},{"@type":"ListItem","position":3,"name":"IRLAB presenterar vid konferensen Bayes@Lund 2024 i Lund den 7 mars"}]},{"@type":"WebSite","@id":"https:\/\/irlab.se\/#website","url":"https:\/\/irlab.se\/","name":"Irlab","description":"Novel treatments for Parkinson's disease","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/irlab.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/mfn_news\/11320","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/media?parent=11320"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}